Article

Determination of Hormone Receptors, Human Epidermal Growth Factor Receptor 2 and Ki67 Status in Invasive Breast Carcinoma: A Concordance Study between Immunohistochemistry, Fluorescence in Situ Hybridization, and GeneXpert® Breast Cancer STRAT4 Assay

2021-11-23

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>The accurate assessment of hormone receptors (ER and PR), HER2 and Ki-67 proliferative index provides meaningful information about breast cancer prognosis and prediction of therapy response. Immunohistochemistry, the most common method for evaluating these prognostic biomarkers, can be impacted by numerous variabilities due to pre-analytical/analytical factors and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f720f4ba-e38c-5252-8c89-fd62a902e8a8
DOI: 10.21203/rs.3.rs-1044271/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Determination of Hormone Receptors, Human Epidermal Growth Factor Receptor 2 and Ki67 Status in Invasive Breast Carcinoma: A Concordance Study between Immunohistochemistry, Fluorescence in Situ Hybridization, and GeneXpert® Breast Cancer STRAT4 AssayDOI 10.21203/rs.3.rs-1044271/v1Read

Comparing Molecular Biomarker Testing With Immunohistochemical Staining In Predicting Response To Neoadjuvant Therapy In Breast CancerSemantic proximity Read

Looking for more reliable biomarkers in breast cancer: Comparison between routine methods and RT-qPCRSemantic proximity Read

Biomarker assessment and molecular testing for prognostication in breast cancerSemantic proximity Read

Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An updateSemantic proximity Read

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerSemantic proximity Read

Triple-negative breast cancer: a threshold-defined diagnostic category within a biological continuum.Semantic proximity Read

Multimodal histopathologic models stratify hormone receptor-positive early breast cancerSemantic proximity Read

Testing for ESR1 Mutations to Guide Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update.Semantic proximity Read

PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular MarkersSemantic proximity Read

Survival analysis in breast cancer using proteomic data from four independent datasetsSemantic proximity Read

The hormone receptor status in breast cancer and the relationship of subtypes with clinicopathological features.Semantic proximity Read

Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations.Semantic proximity Read